In summary, down-regulated protein levels of Ang-2 and soluble endoglin in plasma represent potential HHT biomarkers in the biochemical diagnosis of HHT facilitating the rapid identification of suspected HHT patients. The gene discussed is ANGPT2; the disease is hereditary hemorrhagic telangiectasia.